查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842000

美國抗體特異性檢測市場：市場規模、佔有率、趨勢分析（按產品/服務、技術、應用、最終用途分類）、細分市場預測（2025-2033 年）

U.S. Antibody Specificity Testing Market Size, Share & Trends Analysis Report, By Product & Services, By Technology, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

據估計，2024 年美國抗體特異性檢測市值為 3.173 億美元，預計到 2033 年將達到 5.926 億美元，2025 年至 2033 年的複合年成長率為 7.39%。

市場成長主要受抗體療法和診斷方法應用日益廣泛以及對研究可重複性日益重視的推動。高通量篩檢和流式細胞技術等檢驗方法的進步，以及美國強大的研究基礎設施和資金支持，預計將進一步加速抗體技術的應用。

疾病負擔日益加重

在美國，推動抗體特異性檢測市場需求成長的主要因素之一是日益加重的疾病負擔，尤其是癌症、自體免疫疾病和感染疾病的盛行率不斷上升。抗體在識別疾病生物標記、監測疾病進展以及開發標靶治療方法方面發揮關鍵作用。隨著美國慢性病盛行率的持續成長，醫療保健提供者和研究人員越來越重視檢驗抗體的準確性和特異性，以確保診斷和治療結果的可靠性。

此外，隨著治療策略越來越依賴生物標記主導的方法，個人化和精準醫療的興起推動了對高特異性抗體的需求。抗體特異性檢測能夠篩選和檢驗可精準標靶化疾病路徑且無交叉反應的抗體，從而改善患者預後並降低無效治療的風險。在美國，檢測技術的進步和強大的研發投入推動了對高品質、經驗證抗體的需求不斷成長，預計這將繼續成為預測期內推動市場擴張的核心因素。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場關聯性展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析

第4章：依產品/服務進行業務分析

  • 產品/服務儀錶板
  • 美國抗體特異性檢測市場：按產品和服務分類的差異分析
  • 美國抗體特異性檢測市場規模及趨勢分析（按產品及服務分類）（2021-2033 年）
  • 產品
    • 產品市場（2021-2033）
    • 抗體
    • 管理和標準
    • 套件和試劑
    • 基因檢驗工具
  • 抗體檢驗和特異性測試服務
    • 抗體檢驗與特異性檢測服務市場（2021-2033）

第5章：依技術進行業務分析

  • 技術儀錶板
  • 美國抗體特異性檢測市場：依技術分類的差異分析
  • 美國抗體特異性檢測市場規模及趨勢分析（按技術分類）（2021-2033 年）
  • 基於免疫檢測的技術
    • 免疫檢測分析技術市場（2021-2033）
    • 西方印漬術
    • 免疫化學
    • 流式細胞技術
    • 其他
  • 基於基因檢驗的技術
    • 基於基因檢驗的技術市場（2021-2033）
  • 基於微陣列的抗體技術
    • 基於微陣列的抗體技術市場（2021-2033）
  • 其他技術
    • 其他技術市場（2021-2033）

第6章：按應用程式進行業務分析

  • 特定用途的儀錶板
  • 美國抗體特異性檢測市場：按應用分類的差異分析
  • 美國抗體特異性檢測市場規模及應用趨勢分析（2021-2033）
  • 研究與開發
    • 研發市場（2021-2033）
    • 藥物研發
    • 蛋白質體學和生物標記發現
  • 臨床診斷
    • 臨床診斷市場（2021-2033）
    • 感染疾病
    • 腫瘤學
    • 免疫學與自體免疫疾病
    • 神經退化性疾病
    • 代謝紊亂
    • 其他

第7章 依最終用途進行業務分析

  • 終端用戶儀錶板
  • 美國抗體特異性檢測市場：依最終用途分類的差異分析
  • 美國抗體特異性檢測市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
  • 製藥和生物技術公司
    • 醫藥和生物技術市場（2021-2033）
  • 學術研究機構
    • 學術研究機構市場（2021-2033）
  • 診斷實驗室
    • 診斷實驗室市場（2021-2033）
  • 其他用途
    • 其他終端用戶市場（2021-2033 年）

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Cell Signaling Technology, Inc.
    • BD
    • Novus Biologicals
    • OriGene Technologies, Inc.
    • Creative Diagnostics
    • GenScript
Product Code: GVR-4-68040-738-1

Market Size & Trends:

The U.S. antibody specificity testing market size was estimated at USD 317.3 million in 2024 and is projected to reach USD 592.6 million by 2033, growing at a CAGR of 7.39% from 2025 to 2033. The market growth is driven by the rising use of antibody-based therapeutics and diagnostics, coupled with the growing focus on research reproducibility. Advancements in validation methods such as high-throughput screening and flow cytometry, along with strong U.S. research infrastructure and funding support, are expected to accelerate adoption further.

Growing disease burden

One of the major factors driving demand in the U.S. antibody specificity testing market is the growing disease burden, particularly the rising prevalence of cancer, autoimmune disorders, and infectious diseases. These conditions have significantly increased the reliance on antibody-based diagnostics and therapeutics, as antibodies play a crucial role in identifying disease biomarkers, monitoring disease progression, and developing targeted treatment approaches. With the U.S. witnessing a steady increase in chronic disease incidence, healthcare providers and researchers are placing greater emphasis on validating the accuracy and specificity of antibodies to ensure reliable diagnostic and therapeutic outcomes.

Moreover, the shift toward personalized and precision medicine has amplified the need for highly specific antibodies, as treatment strategies increasingly depend on biomarker-driven approaches. Antibody specificity testing enables the selection and validation of antibodies that can accurately target disease pathways without cross-reactivity, thereby improving patient outcomes and reducing risks of ineffective treatment. This growing demand for high-quality, validated antibodies supported by advances in testing technologies and strong U.S. R&D investment will remain a core driver of market expansion throughout the forecast period.

U.S. Antibody Specificity Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. antibody specificity testing market on the basis of product & services, technology, application, and end-use:

  • Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • Antibodies
    • Control & Standards
    • Kits & Reagents
    • Gene Validation Tools
  • Antibody Validation & Specificity Testing Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay-based Technologies
    • Western Blotting
    • Immunochemistry
    • Flow Cytometry
    • Others
  • Genetic Validation-based Technologies
  • Microarray-based Antibody Technologies
  • Other Technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research & Development
    • Drug Discovery & Development
    • Proteomics & Biomarker Discovery
  • Clinical Diagnostics
    • Infectious Diseases
    • Oncology
    • Immunology & Autoimmune Disorders
    • Neurodegenerative Disorders
    • Metabolic Disorders
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Other End Use

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product & Services
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
  • 1.2. Market Definitions
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Others
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing disease burden
      • 3.2.1.2. Advances in technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technical complexity and reproducibility challenges
      • 3.2.2.2. High cost of advanced validation technologies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. U.S. Antibody Specificity Testing Market: Product & Services Movement Analysis
  • 4.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market, 2021 - 2033 (USD Million)
    • 4.4.2. Antibodies
      • 4.4.2.1. Antibodies Market, 2021 - 2033 (USD Million)
    • 4.4.3. Control & Standards
      • 4.4.3.1. Control & Standards Market, 2021 - 2033 (USD Million)
    • 4.4.4. Kits & Reagents
      • 4.4.4.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
    • 4.4.5. Gene Validation Tools
      • 4.4.5.1. Gene Validation Tools Market, 2021 - 2033 (USD Million)
  • 4.5. Antibody Validation & Specificity Testing Services
    • 4.5.1. Antibody Validation & Specificity Testing Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Product & Services Segment Dashboard
  • 5.2. U.S. Antibody Specificity Testing Market: Technology Movement Analysis
  • 5.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Immunoassay-based Technologies
    • 5.4.1. Immunoassay-based Technologies Market, 2021 - 2033 (USD Million)
    • 5.4.2. Western Blotting
      • 5.4.2.1. Western Blotting Market, 2021 - 2033 (USD Million)
    • 5.4.3. Immunochemistry
      • 5.4.3.1. Immunochemistry Market, 2021 - 2033 (USD Million)
    • 5.4.4. Flow Cytometry
      • 5.4.4.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Genetic Validation-based Technologies
    • 5.5.1. Genetic Validation-based Technologies Market, 2021 - 2033 (USD Million)
  • 5.6. Microarray-based Antibody Technologies
    • 5.6.1. Microarray-based Antibody Technologies Market, 2021 - 2033 (USD Million)
  • 5.7. Other Technologies
    • 5.7.1. Other Technologies Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. U.S. Antibody Specificity Testing Market: Application Movement Analysis
  • 6.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Research & Development
    • 6.4.1. Research & Development Market, 2021 - 2033 (USD Million)
    • 6.4.2. Drug Discovery & Development
      • 6.4.2.1. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
    • 6.4.3. Proteomics & Biomarker Discovery
      • 6.4.3.1. Proteomics & Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 6.5. Clinical Diagnostics
    • 6.5.1. Clinical Diagnostics Market, 2021 - 2033 (USD Million)
    • 6.5.2. Infectious Diseases
      • 6.5.2.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 6.5.3. Oncology
      • 6.5.3.1. Oncology Market, 2021 - 2033 (USD Million)
    • 6.5.4. Immunology & Autoimmune Disorders
      • 6.5.4.1. Immunology & Autoimmune Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.5. Neurodegenerative Disorders
      • 6.5.5.1. Neurodegenerative Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.6. Metabolic Disorders
      • 6.5.6.1. Metabolic Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. U.S. Antibody Specificity Testing Market: End Use Movement Analysis
  • 7.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.5. Academic and Research Institutions
    • 7.5.1. Academic and Research Institutions Market, 2021 - 2033 (USD Million)
  • 7.6. Diagnostic Laboratories
    • 7.6.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
  • 7.7. Other End Use
    • 7.7.1. Other End Use Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Danaher
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Bio-Rad Laboratories, Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cell Signaling Technology, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. BD
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Novus Biologicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. OriGene Technologies, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Creative Diagnostics
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. GenScript
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. Antibody Specificity Testing Market, By Product & Services, 2021 - 2033 (USD Million)
  • Table 5 U.S. Antibody Specificity Testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 U.S. Antibody Specificity Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 U.S. Antibody Specificity Testing Market, By End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 U.S. antibody specificity testing market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis
  • Fig. 11 Market restraint relevance analysis
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 U.S. antibody specificity testing market: Product & services movement analysis
  • Fig. 15 U.S. antibody specificity testing market, for product, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. antibody specificity testing market, for kits & reagents, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. antibody specificity testing market, for antibodies, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. antibody specificity testing market, for control & standards, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. antibody specificity testing market, for gene validation tools, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. antibody specificity testing market, for antibody validation & specificity testing services, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. antibody specificity testing market: Technology movement analysis
  • Fig. 22 U.S. antibody specificity testing market, for immunoassay-based technologies, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. antibody specificity testing market, for western blotting, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. antibody specificity testing market, for immunochemistry, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. antibody specificity testing market, for flow cytometry, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. antibody specificity testing market, for genetic validation-based technologies, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. antibody specificity testing market, for microarray-based antibody technologies, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. antibody specificity testing market, for other technologies, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. antibody specificity testing market: Application movement analysis
  • Fig. 31 U.S. antibody specificity testing market, for research and development, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. antibody specificity testing market, for drug discovery & development, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. antibody specificity testing market, for proteomics & biomarker discovery, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. antibody specificity testing market, for clinical diagnostics, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. antibody specificity testing market, for oncology, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. antibody specificity testing market, for infectious diseases, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. antibody specificity testing market, for immunology & autoimmune disorders, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. antibody specificity testing market, for neurodegenerative disorders, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. antibody specificity testing market, for metabolic disorders, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. antibody specificity testing market: End Use movement analysis
  • Fig. 42 U.S. antibody specificity testing market, for academic and research institutions, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. antibody specificity testing market, for pharmaceutical and biotechnology companies, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. antibody specificity testing market, for diagnostic laboratories, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. antibody specificity testing market, for other end use, 2021 - 2033 (USD Million)